1. Home
  2. IGC vs WIMI Comparison

IGC vs WIMI Comparison

Compare IGC & WIMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IGC
  • WIMI
  • Stock Information
  • Founded
  • IGC 2005
  • WIMI 2015
  • Country
  • IGC United States
  • WIMI China
  • Employees
  • IGC N/A
  • WIMI N/A
  • Industry
  • IGC Biotechnology: Pharmaceutical Preparations
  • WIMI Computer Software: Prepackaged Software
  • Sector
  • IGC Health Care
  • WIMI Technology
  • Exchange
  • IGC Nasdaq
  • WIMI Nasdaq
  • Market Cap
  • IGC 39.8M
  • WIMI 38.3M
  • IPO Year
  • IGC N/A
  • WIMI 2020
  • Fundamental
  • Price
  • IGC $0.42
  • WIMI $3.91
  • Analyst Decision
  • IGC Strong Buy
  • WIMI
  • Analyst Count
  • IGC 2
  • WIMI 0
  • Target Price
  • IGC $4.00
  • WIMI N/A
  • AVG Volume (30 Days)
  • IGC 1.4M
  • WIMI 233.8K
  • Earning Date
  • IGC 08-14-2025
  • WIMI 01-01-0001
  • Dividend Yield
  • IGC N/A
  • WIMI N/A
  • EPS Growth
  • IGC N/A
  • WIMI N/A
  • EPS
  • IGC N/A
  • WIMI 1.00
  • Revenue
  • IGC $1,327,000.00
  • WIMI $74,245,408.00
  • Revenue This Year
  • IGC $15.26
  • WIMI N/A
  • Revenue Next Year
  • IGC $3.41
  • WIMI N/A
  • P/E Ratio
  • IGC N/A
  • WIMI $3.88
  • Revenue Growth
  • IGC 24.95
  • WIMI N/A
  • 52 Week Low
  • IGC $0.25
  • WIMI $2.24
  • 52 Week High
  • IGC $0.50
  • WIMI $29.20
  • Technical
  • Relative Strength Index (RSI)
  • IGC 55.05
  • WIMI 53.43
  • Support Level
  • IGC $0.39
  • WIMI $3.58
  • Resistance Level
  • IGC $0.47
  • WIMI $4.07
  • Average True Range (ATR)
  • IGC 0.04
  • WIMI 0.22
  • MACD
  • IGC 0.00
  • WIMI -0.01
  • Stochastic Oscillator
  • IGC 43.67
  • WIMI 63.34

About IGC IGC Pharma Inc.

IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.

About WIMI WiMi Hologram Cloud Inc.

WiMi Hologram Cloud Inc and its subsidiaries offer augmented reality (AR) based holographic services and products to cater to its customers. Its AR service and product offerings consist of holographic AR advertising services and holographic AR entertainment products. It is also into the semiconductor business, in which the company provides central processing algorithm services and computer chip products to enterprise customers and the sales of comprehensive solutions for central processing algorithms and related services with software and hardware integration. The company reports in three segments: AR advertising, AR entertainment, and Semiconductor. Its geographical segments are Mainland China, Hong Kong, and International.

Share on Social Networks: